NEW YORK, Oct. 4, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm appointed
"As a leading independent voice in healthcare, Chardan is excited to continue building our platform with industry veterans. Peter's experience and leadership will be instrumental in expanding our offering to our corporate clients," said Jonas Grossman, President of Chardan. "Peter's deep M&A and advisory expertise, capital markets capabilities and transactional experience as a trusted advisor to healthcare companies complement the Chardan franchise."
Prior to Chardan, Mr. Lang served as Managing Director and Head of North America Healthcare Investment Banking & Advisory at HSBC. Mr. Lang also drove the biotech investment banking effort at FBR and worked at Leerink Partners as an M&A healthcare banker. Additionally, he served as a senior member of the biopharmaceutical investment banking teams in the healthcare groups of Bank of America Merrill Lynch, UBS Investment Bank and Merrill Lynch. Mr. Lang also previously helped run the effort to build Macquarie Capital's investment banking M&A franchise in the U.S.
Mr. Lang graduated magna cum laude with dual B.S. and B.A. degrees from the University of Pennsylvania's Wharton Business School and School of Arts & Sciences, and earned an M.B.A. with high honors from the Booth School of Business at the University of Chicago.
Over the course of Mr. Lang's investment banking career, he has advised on over 40 M&A transactions with an estimated value of $25 billion and raised over $100 billion in more than 115 equity, convertible and debt financings, primarily for growth, acquisition and investment capital.
Chardan provides a full suite of Global Investment Banking services designed for micro, small and mid-cap emerging growth companies. Our full range of services includes capital raising, merger and acquisition advisory, strategic advisory, equity research, institutional trading and market making. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc.
To learn more about Chardan, visit www.chardan.com
Emily Levine, Chardan firstname.lastname@example.org (646) 465-9018
Thomas J. Rozycki Jr., Prosek Partners email@example.com (646) 503-5657
View original content:http://www.prnewswire.com/news-releases/peter-lang-joins-chardan-as-managing-director-300724134.html
SOURCE Chardan Capital Markets, LLC
Subscribe to our Free Newsletters!
A lump in the armpit can be due to a benign infection, allergy or fatty tissue growth. It is ...
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...
True vertigo is a severe form of dizziness that is a movement hallucination. Try out some of these ...View All